Report Top-Line Results from Phase II CLEAR Trial YE 2015: CLASSIC Trial in 1H 2016
Initiate Phase III in AAV in 2H 2016
Report Early Results from Pancreatic Cancer Study Q4 2015 and 1H 2016
CCX354: Rheumatoid Arthritis/Myeloma Bone Metastasis (CCR1)
Explore Partnering Options to Advance Program in IBD
CCR1 CCX354 Completed Phase IIa
Progress in TH17 Disease
* also known as CCX282 or Traficet-EN.